原发性肝癌介入治疗后急性肾功能衰竭的预防及治疗

目的：探讨原发性肝癌介入治疗后急性肾功能衰竭的风险因素、预防及治疗措施。方法：回顾性分析4例原发性肝癌介入治疗后发生急性肾功能衰竭的临床表现及治疗情况。结果：4例患者均为巨块型肝癌,首次行介入治疗,术前肝功能ChildA级,肾功能正常,介入后72h内发生急性肾功能衰竭,2例经血液透析后恢复,1例经补液利尿治疗后恢复,1例合并糖尿病、高血压的年老患者死于心力衰竭。结论：介入后发生急性肾功能衰竭是少见而严重的并发症,对于高风险的患者应采取有效的防范措施。

Prevention and treatment of acute renal failure after transarterial chemoembolization for hepatocellular carcinoma

Objective：To investigate the risk factors and methods of prevention and treatment in patients of acute renal failure （ARF） with hepatocellular carcinoma （HCC） after transarterial chemoembolization （TACE）.Methods：The clinical records of 4 patients with the occurrence of ARF after TACE were retrospectively studied.Resusts：Four pantients with giant hepatocellular carcinomas received TACE for the first time,they fulfilled the following criteria before treatment：Child-Pugh function class A;normal renal function.ARF developed within 72h after TACE.Two patients undergoing hemodialysis and one given intravenous fluids and diuretic were healed and discharged from hospital,one elderly patient with diabetic and hypertension died of heart failure.Conclusion：ARF in the patients with HCC after TACE is a rare and severe complication.Effective preventive measures should be undertaken especially in high-risk patients.